Cytomegalovirus Hyperimmune Globulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cytomegalovirus Hyperimmune Globulin, covering 2011-12-08 to 2011-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection [Phase 2, Phase 3]